Loading…
Includes $4.7 million upfront and $8.3 million from warrants
Cocrystal Pharma, Inc. (COCP) announced on September 12, 2025, a registered direct offering of up to $13 million in common stock and warrants. The offering includes $4.7 million in upfront proceeds and $8.3 million in potential gross proceeds from the exercise of warrants.
The company plans to issue 2,764,710 shares at $1.70 per share and warrants to purchase up to 5,529,420 shares with an exercise price of $1.50 per share. There are no conflicts of interest or comparisons provided in the announcement.
As of the latest data, Cocrystal Pharma has a free float of 9,326,600 shares and 13,784,100 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.